Category: Biotech
Focused Monitoring Support for Rare Disease Study A small biotech needed functional support for a Phase III rare disease study. Although a contract
existed between the biotech and a clinical research organization (CRO), the study timelines and budget
had slipped. The biotech hired Catalyst Flex to reverse that trend and ultimately saved ~$1 million. Read Now 
Impacts of Project Optimus on Oncology Trial Costs Exploring creative financial solutions for biotechs Navigating the evolving landscape of early-phase drug development has Read Now 
Providing Support to Succeed Catalyst Flex delivers clinical monitoring oversight experts on Phase III global study Situation A small Read Now 
Webinar: Clinical Trial Flexibility and Customization Needs that Are Required by Biotechs and Next-generation Therapies COVID-19 has ushered in new challenges when conducting clinical trials, but mid-tier biotech companies have Read Now